Brief: Spectracure Gets Approval From German Drug Authority For Prostate Cancer Study

SpectraCure AB (publ)

05/06/2025 14:04

June 5 (Reuters) - SpectraCure AB (publ) SPEC.ST:

RECEIVES APPROVAL FROM GERMAN DRUG AUTHORITY FOR PROSTATE CANCER STUDY

Source text: ID:nMFN5GmQHJ

Further company coverage: SPEC.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))